About Cancer Crosslinks

Cancer Crosslinks is an annual educational meeting series bringing together international key opinion leaders in oncology alongside Norwegian experts.

Established in 2009 by Oslo Cancer Cluster in collaboration with Bristol Myers Squibb, it serves as a leading forum for oncologists, haematologists, translational researchers, healthcare providers, regulatory experts, patients and industry representatives to exchange insights on the latest advances in cancer diagnostics and treatments.

Related article

Cancer Crosslinks at 18: Mapping and mastering complexity in modern oncology

When Cancer Crosslinks took place in Oslo on January 22, it marked the meeting’s 18th anniversary. It’s “really coming of age,” jokes Jutta Heix, the Head of International Affairs at Oslo Cancer Cluster, which organizes the meeting.

Cancer Innovation Award ceremony

During Cancer Crosslinks 2027, the Norwegian Cancer Society will also present the winner of its Innovation Award, with nominations opening shortly after the summer.

Registration & programme

Registration will open this autumn, with more details about the programme to be published closer to the event.